https://scholars.lib.ntu.edu.tw/handle/123456789/556996
標題: | Comprehensive cohort analysis of mutational spectrum in early onset breast cancer patients | 作者: | Midha M.K. Huang Y.-F. Yang H.-H. Fan T.-C. Chang N.-C. Chen T.-H. Wang Y.-T. WEN-HUNG KUO KING-JEN CHANG Shen C.-Y. Yu A.L. Chiu K.-P. Chen C.-J. |
關鍵字: | Early onset breast cancer (EOBC); Germline mutations; Missense mutations; Nonsynonymous mutations; Somatic mutations | 公開日期: | 2020 | 出版社: | MDPI AG | 卷: | 12 | 期: | 8 | 起(迄)頁: | 1-17 | 來源出版物: | Cancers | 摘要: | Early onset breast cancer (EOBC), diagnosed at age ~40 or younger, is associated with a poorer prognosis and higher mortality rate compared to breast cancer diagnosed at age 50 or older. EOBC poses a serious threat to public health and requires in-depth investigation. We studied a cohort comprising 90 Taiwanese female patients, aiming to unravel the underlying mechanisms of EOBC etiopathogenesis. Sequence data generated by whole-exome sequencing (WES) and whole-genome sequencing (WGS) from white blood cell (WBC)–tumor pairs were analyzed to identify somatic missense mutations, copy number variations (CNVs) and germline missense mutations. Similar to regular breast cancer, the key somatic mutation-susceptibility genes of EOBC include TP53 (40% prevalence), PIK3CA (37%), GATA3 (17%) and KMT2C (17%), which are frequently reported in breast cancer; however, the structural protein-coding genes MUC17 (19%), FLG (16%) and NEBL (11%) show a significantly higher prevalence in EOBC. Furthermore, the top 2 genes harboring EOBC germline mutations, MUC16 (19%) and KRT18 (19%), encode structural proteins. Compared to conventional breast cancer, an unexpectedly higher number of EOBC susceptibility genes encode structural proteins. We suspect that mutations in structural proteins may increase physical permeability to environmental hormones and carcinogens and cause breast cancer to occur at a young age. ? 2020 by the authors. Licensee MDPI, Basel, Switzerland. |
URI: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85089127023&doi=10.3390%2fcancers12082089&partnerID=40&md5=5f4570ba5a8cf5a78e8170fd53ac21a4 https://scholars.lib.ntu.edu.tw/handle/123456789/556996 |
ISSN: | 2072-6694 | DOI: | 10.3390/cancers12082089 | SDG/關鍵字: | protein p53; transcription factor GATA 3; adult; Article; breast cancer; cohort analysis; copy number variation; disease course; female; FLG gene; GATA3 gene; gene mutation; genetic code; genetic susceptibility; germline mutation; human; human cell; human tissue; KMT2C gene; KRT18 gene; leukocyte; major clinical study; missense mutation; MUC16 gene; MUC17 gene; NEBL gene; oncogene; pathogenesis; PIK3CA gene; prevalence; protein structure; somatic mutation; Taiwanese; TP53 gene; whole exome sequencing; whole genome sequencing |
顯示於: | 醫學系 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。